Literature DB >> 6261923

The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary.

M C Galli, C De Giovanni, G Nicoletti, S Grilli, P Nanni, G Prodi, G Gola, R Rocchetta, C Orlandi.   

Abstract

The cytoplasmic receptors for 17 beta-estradiol (ER), 5 alpha-dihydrotestosterone (AR), progesterone (PR), and cortisol (GR) have been quantified in 36 specimens from the human ovary (13 disease-free, 5 benign, and 18 malignant) by a dextran-coated charcoal (DCC) technique. The occurrence of receptor-positive biopsies were: ER 46%, AR 85%, PR 54%, GR 92%, in normal tissue; ER 40%, AR 100%, PR 20%, GR 50%, in benign tumors; and ER 67%, AR 72%, PR 50%, GR 88%, in malignant lesions. Furthermore, the simultaneous occurrence of ER and PR in malignant tumors was 50% yet all four receptors were found to be present only in 44% of the cases. The findings reported here on the strong correlation existing between ER and PR presence or amount agree with previous observations on normal and neoplastic specimens from human breast and endometrial tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6261923     DOI: 10.1002/1097-0142(19810315)47:6<1297::aid-cncr2820470611>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.

Authors:  Jennifer Taylor Veneris; Kathleen M Darcy; Paulette Mhawech-Fauceglia; Chunqiao Tian; Ernst Lengyel; Ricardo R Lastra; Tanja Pejovic; Suzanne D Conzen; Gini F Fleming
Journal:  Gynecol Oncol       Date:  2017-04-26       Impact factor: 5.482

2.  Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.

Authors:  J G Klijn; F H de Jong; M A Blankenstein; R Docter; J Alexieva-Figusch; J Blonk-van der Wijst; S W Lamberts
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

Review 3.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  Estradiol and progesterone receptors in normal and pathologic colonic mucosa in humans.

Authors:  M Marugo; F Molinari; L Fazzuoli; M C Parodi; D Bernasconi; F Menozzi; G Giordano
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

5.  Dietary factors and epithelial ovarian cancer.

Authors:  X O Shu; Y T Gao; J M Yuan; R G Ziegler; L A Brinton
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

6.  Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?

Authors:  S T Malik; M L Slevin
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

7.  17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo.

Authors:  Laura A Laviolette; Kendra M Hodgkinson; Neha Minhas; Carol Perez-Iratxeta; Barbara C Vanderhyden
Journal:  Int J Cancer       Date:  2014-02-25       Impact factor: 7.396

8.  Effects of a gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo.

Authors:  T Maruuchi; T Sugiyama; A Kataoka; T Nishida; M Yakushiji
Journal:  Jpn J Cancer Res       Date:  1998-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.